Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Well there's your answer folks!!
Sadly, I tend to agree.  Our patents are a viable product that hundreds of companies use and must license.  To me, that money is as valid as any other revenue generated by selling a product whatever it may be.  Why the market doesn't recognize this is beyond me.  Something is missing from this equation... USPTO validation perhaps?   Also, Turley must steer this company into something viable, something that will generate even more income beyond the shelf life of our patents.  It isn't right, but what other answer is there for us?
Share
New Message
Please login to post a reply